Literature DB >> 20122120

Opioid contracts and random drug testing for people with chronic pain - think twice.

Mark Collen1.   

Abstract

The use of opioid contracts, which often require patients to submit to random drug screens, have become widespread amongst physicians using opioids to treat chronic pain. The main purpose of the contract is to improve care through better adherence to opioid therapy but there is little evidence as to its efficacy. The author suggests the use of opioid contracts and random drug testing destroys patients' trust which impacts health outcomes, and that physicians' motivation for their use are concerns about prosecution, medication abuse and misuse, and addiction. Statistics are provided to counter fears, and evidence is offered suggesting opioid contracts are unenforceable and lack efficacy; random drug testing is often inconclusive, and a patient's trust improves adherence to treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20122120     DOI: 10.1111/j.1748-720X.2009.00455.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  10 in total

Review 1.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

2.  Developing and Initiating Validation of a Model Opioid Patient-Prescriber Agreement as a Tool for Patient-Centered Pain Treatment.

Authors:  Mary P Ghods; Ian T Schmid; Carol A Pamer; Brian M Lappin; Dale C Slavin
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

3.  It made my life a little easier: primary care providers' beliefs and attitudes about using opioid treatment agreements.

Authors:  Joanna L Starrels; Bryan Wu; Deena Peyser; Aaron D Fox; Abigail Batchelder; Frances K Barg; Julia H Arnsten; Chinazo O Cunningham
Journal:  J Opioid Manag       Date:  2014 Mar-Apr

4.  Power and control: contracts and the patient-physician relationship.

Authors:  S R Lieber; S Y Kim; M L Volk
Journal:  Int J Clin Pract       Date:  2011-12       Impact factor: 2.503

5.  Perceptions of patient provider agreements.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Françoise Pradel; Michelle Campbell; Jacqueline Palmer; Ilene Harris; Francis Palumbo
Journal:  J Pharm Health Serv Res       Date:  2015-06-16

6.  Resident and Patient Responses to the Institution of Required Narcotic Agreements in an Internal Medicine Outpatient Clinic.

Authors:  Melissa M Butler; Randy A Sansone; Charles Opperman
Journal:  Innov Clin Neurosci       Date:  2015 Sep-Oct

Review 7.  2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

Authors:  R Douglas Bruce; Jessica Merlin; Paula J Lum; Ebtesam Ahmed; Carla Alexander; Amanda H Corbett; Kathleen Foley; Kate Leonard; Glenn Jordan Treisman; Peter Selwyn
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

8.  How Do Clinicians of Different Specialties Perceive and Use Opioid Risk Mitigation Strategies? A Qualitative Study.

Authors:  Michelle S Keller; Alma Jusufagic; Teryl K Nuckols; Jack Needleman; MarySue V Heilemann
Journal:  Subst Use Misuse       Date:  2021-05-22       Impact factor: 2.164

9.  Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.

Authors:  Celia Oreja-Guevara; Stanca Potra; Birgit Bauer; Diego Centonze; Maria-Paz Giambastiani; Gavin Giovannoni; Jürg Kesselring; Dawn Langdon; Sarah A Morrow; Jocelyne Nouvet-Gire; Maija Pontaga; Peter Rieckmann; Sven Schippling; Nektaria Alexandri; Jane Shanahan; Heidi Thompson; Pieter Van Galen; Patrick Vermersch; David Yeandle
Journal:  Adv Ther       Date:  2019-09-05       Impact factor: 3.845

10.  Demographic Patterns Associated With Compliance in Pain Contract Patients: A Residency Clinic Experience.

Authors:  Sourabh Aggarwal; Ravikanth Papani; Mazen Roumia; Susan Bannon
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.